‌

US Patent 7405273 Chimeric immunogens

Patent 7405273 was granted and assigned to Sanofi Pasteur on July, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Sanofi Pasteur

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74052730

Patent Inventor Names

Run-Pan Du0

Mary E. Ewasyshyn0

Michel H. Klein0

Date of Patent

July 29, 2008

Patent Application Number

118088000

Date Filed

June 13, 2007

Patent Primary Examiner

‌

Mark Navarro

Patent abstract

Multimeric hybrid genes encoding the corresponding chimeric protein comprise a gene sequence coding for an antigenic region of a protein from a first pathogen linked to a gene sequence coding for an antigenic region of a protein from a second pathogen. The pathogens particularly are parainfluenza virus (PIV) and respiratory syncytial virus (RSV). A single recombinant immunogen is capable of protecting infants and similar susceptible individuals against diseases caused by both PIV and RSV.